1-2 of 2
B. Douglas Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML

Open Access
Andrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, Mark J Levis, Ivana Gojo, Amy E DeZern, Gabriel Ghiaur, Lukasz P Gondek, William Brian Dalton, Theodoros Karantanos, Tania Jain, Gabrielle T Prince, Richard J Jones, B. Douglas Smith, Alexander J Ambinder
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (4): 100133.
https://doi.org/10.1016/j.bneo.2025.100133
Published: 2025
Includes: Supplemental data
Journal Articles

Ivosidenib or venetoclax combined with hypomethylating agents in IDH1 -mutated acute myeloid leukemia: a real-world study

Open Access
Curtis A. Lachowiez, B. Douglas Smith, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Ravi Potluri, Eros Papademetriou, Thomas W. LeBlanc
Journal: Blood Neoplasia
Blood Neoplasia 100152.
https://doi.org/10.1016/j.bneo.2025.100152
Published: 2025